Cefazolin Leads to Better Outcomes for Methicillin-susceptible Staphylococcus aureus Bacteremia Than Nafcillin or Oxacillin.

Title

Cefazolin Leads to Better Outcomes for Methicillin-susceptible Staphylococcus aureus Bacteremia Than Nafcillin or Oxacillin.

Creator

Watkins Richard R

Publisher

Infectious Disease Alert

Date

2017
2017-08

Description

A retrospective study that included patients from 119 Veterans Affairs hospitals found lower mortality and a similar recurrence rate for methicillin-susceptible Staphylococcus aureus bacteremia treated with cefazolin compared to nafcillin and oxacillin.

Subject

Treatment Outcomes; Staphylococcal Infections – Drug Therapy; Treatment Outcomes – Evaluation; Bacteremia – Drug Therapy; Cefazolin – Therapeutic Use; Drug Therapy – Evaluation; Nafcillin – Therapeutic Use; Oxacillin – Therapeutic Use; Vancomycin – Therapeutic Use

Rights

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

Pages

3–4

Issue

11

Volume

36

Citation

Watkins Richard R, “Cefazolin Leads to Better Outcomes for Methicillin-susceptible Staphylococcus aureus Bacteremia Than Nafcillin or Oxacillin.,” NEOMED Bibliography Database, accessed September 24, 2021, https://neomed.omeka.net/items/show/5807.

Social Bookmarking